<DOC>
	<DOC>NCT01330771</DOC>
	<brief_summary>To assess the effectiveness of a protocol of ovarian hyperstimulation combining urinary gonadotrophins + recombinant gonadotrophins, to achieve clinical pregnancy in females undergoing IVF. Study hypothesis: to assess the effectiveness of protocols combining urinary gonadotrophins + recombinant gonadotrophins</brief_summary>
	<brief_title>Assessment of the Therapeutic Utility of r-FSH in Association With hMG-HP</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<criteria>Women aged 1838 years Body mass index (BMI) between 18 and 30 Women classified as normogonadotrophin patients. Not more than 3 previous cycles of ART (assisted reproductive technology) Testosterona, FSH (folliclestimulating hormone), LH (luteinizing hormone) and Prolactin serum levels during the early folicular phase (days 24 of the cycle) within the laboratory normal range No administration of clomiphen citrate or gonadotropins during the month prior to the start of the study Failure in previous cycles of assisted reproduction IVF/ICSI (invitro fertilisation/intracytoplasmic sperm injection) Seminal samples not apt for IVFICSI (according to the criteria of each center). Evidence of significant bacterial infection in the seminogram of the couple in the preceding 6 months Data suggestive of possible ovarian failure Antecedents of severe ovarian hyperstimulation syndrome (OHSS) Important systemic disease Pregnancy or contraindication to pregnancy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>38 Years</maximum_age>
	<verification_date>April 2011</verification_date>
</DOC>